Wealth Manager - the site for professional investment managers

Register to get unlimited access to Citywire’s fund manager database. Registration is free and only takes a minute.

IMA urges regulator to rethink its Ucis sales ban

IMA urges regulator to rethink its Ucis sales ban

The Investment Management Association (IMA) has urged the regulator to rethink its proposals on restricting the sale of unregulated collective investment schemes (Ucis).

As revealed by Wealth Manager last month, the Financial Services Authority (FSA) is pushing ahead with its plans to curb the retail distribution of some Ucis, despite industry opposition to the move.

The IMA, trade body for the investment and funds sector, has in part backed the FSA's plans but it feels the regulator has been too broad brushed in its definitions and its crackdown on Ucis as a whole.

'We welcome the FSA's proposals which are intended to protect consumers from the sale of unsuitable, high risk or otherwise inappropriate products that have been evidenced to cause consumer detriment.

'However, we are concerned the definition of non-mainstream pooled investments is too broadly drawn and would appear to capture investment vehicles that have very similar characteristics to those products that are, and will continue to be, widely available to retail consumers,' the IMA said.

'We would urge the FSA to re-consider and tighten up the definition.  Equally, we are concerned the FSA is adopting a broad brush policy of seeking to ban Ucis when, in our view, the FSA already has the tools to address these issues,' the trade body added.

The IMA's reaction to the Ucis proposals follows the Association of Investment Companies, which represents investment trusts and schemes like enterprise investment schemes and venture capital trusts (VCT), move to urge the FSA to rethink its plans, particularly those for VCT sales.

The IMA has submitted its views to the FSA as part of the regulator's consultation on its planned changes to Ucis sales.

Leave a comment!

Please sign in or register to comment. It is free to register and only takes a minute or two.
Citywire TV
Play Biotech Growth: we will ride out this storm

Biotech Growth: we will ride out this storm

Geoffrey Hsu of Biotech Growth Trust says the sell-off in biotechnology stocks represents a buying opportunity for long-term investors.

Play Sector Spotlight: Kleinwort Benson's Choukeir on UK equities

Sector Spotlight: Kleinwort Benson's Choukeir on UK equities

In our first Sector Spotlight of the year we explore UK equities on the back of the extreme market turbulence in 2016.

Play Picton: the UK property hotspots for rental income

Picton: the UK property hotspots for rental income

Picton Property Income CEO Michael Morris reveals how he is planning to ride the ‘ripple effect’ as UK economic growth spills out from the capital across the country.

Your Business: Cover Star Club

Profile: PortfolioMetrix is on a mission to kill 'Frankenstein' systems

Profile: PortfolioMetrix is on a mission to kill 'Frankenstein' systems

In a buyers’ market for off-the-peg discretionary management, self-funded start-ups begin at an inherent disadvantage

Wealth Manager on Twitter